NASDAQ: PYXS
Pyxis Oncology Inc Stock Ownership - Who owns Pyxis Oncology?

Insider buying vs selling

Have Pyxis Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jakob DupontDirector2026-06-3035,000$1.60
$56.00kBuy
Jakob DupontDirector2026-06-3035,000$3.06
$107.10kSell

1 of 1

PYXS insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PYXS insiders and whales buy or sell their stock.

PYXS Shareholders

What type of owners hold Pyxis Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gordonmd Global Investments LP30.65%25,566,818$43.21MInsider
Pfizer Inc8.43%7,032,770$11.89MInsider
Barclays PLC4.17%3,477,975$5.88MInsider
Pamela Ann Connealy4.11%3,425,179$5.79MInsider
Bayer World Investments Bv3.29%2,742,338$4.63MInsider
Lara Sullivan2.88%2,403,882$4.06MInsider
Cormorant Asset Management LP1.34%1,118,854$1.89MInsider
Jay Feingold0.88%730,345$1.23MInsider
Connealy Pamela Yanchik0.71%594,313$1.00MInsider
Jitendra Wadhane0.61%512,882$866.77kInsider

1 of 3

PYXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PYXS0.04%58.77%Net Buying
UPB0.09%33.20%Net SellingNet Selling
CNTN0.03%7.04%Net Selling
ALXO0.08%10.66%Net BuyingNet Selling
MGNX0.08%37.82%Net SellingNet Buying

Pyxis Oncology Stock Ownership FAQ

Who owns Pyxis Oncology?

Pyxis Oncology (NASDAQ: PYXS) is owned by 0.04% institutional shareholders, 58.77% Pyxis Oncology insiders, and 41.19% retail investors. Gordonmd Global Investments LP is the largest individual Pyxis Oncology shareholder, owning 25.57M shares representing 30.65% of the company. Gordonmd Global Investments LP's Pyxis Oncology shares are currently valued at $47.04M.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.